Recommended by Medical and Care Providers

TempShield™ enables continous real time core body temperature tracking.

Early temperature monitoring is critical - enabling you to identify sustained elevations and the ability to support timely intervention.

TempShield Powers New Standard of Care for Cancer Patients

✓ Continuous body temperature monitoring

✓ 90 day battery

✓ Comfortable design

✓ FDA cleared

✓ Text messages and calls from monitoring team when your temperature triggers an alert

✓ Caregiver connectivity – enables your loved ones to see if you have a fever.

PURCHASE HERE

Real-World Results From Cancer Patients Using TempShield™

91%

Reduction in mortality

75%

Decrease in hospitalization days

98%

Recommended

Perspective observational cohort; individual outcomes may vary.¹

Illustrative Case Study: Continuous Monitoring in Practice
(Tap graph to view fullscreen)

Representative temperature trend. Continuous monitoring captures sustained elevations between scheduled check-ins.

✓ Fever is one of the earliest clinical signals of acute cancer events.

✓ Approximately 40% of cancer patients experience an unplanned hospitalization following diagnosis in the first year.²

✓ Nearly 60% of deaths in high-risk cancer patients is driven by infection.³

What Physicians & Patients Are Saying

“The TempShield is to cancer patients like the glucose monitor is to diabetics. We have seen that the TempShield is the difference between an antibiotic and hospitalization.”

Dr. Tallat Mahmood
MEDICAL DIRECTOR AT ROSWELL PARK CANCER,

ELLIS MEDICINE

“TempShield gives me peace of mind by alerting me when my temperature changes, allowing my care team to act proactively. It has been an excellent experience, and I would recommend it to all cancer patients.”

Maureen Caba
BREAST CANCER PATIENT

“It’s been very comforting having this device on him...to know that if something happens, somebody’s got our back”

Linda Farkas

MOTHER OF ADRENOCORTICAL CANCER PATIENT

TempShield™ at Roswell Park Cancer Center’s Ellis Medicine

Infection Moves Fast, TempShield Moves First

PURCHASE HERE

175 Cabot Street, Suite 100, Lowell, MA 01854, United States

All content on this website, including but not limited to text, graphics, logos, icons, images, and videos, are the exclusive property of AION Biosystems™. Any unauthorized use or reproduction or modification of these materials is prohibited.

1. Mahmood, T., Currier, E., Arogosa, A., Pabba, M., Keleki, Z. G., Li, G., & Montalto, N. (2025). Long-term continuous temperature monitoring at a community cancer center: Towards a new standard of care in oncology. Journal of Clinical Oncology, 43(16_suppl), e13883. https://doi.org/10.1200/JCO.2025.43.16_suppl.e13883

2. Whitney, R. L., Bell, J. F., Tancredi, D. J., Romano, P. S., Bold, R. J., Wun, T., & Joseph, J. G. (2019). Unplanned hospitalization among individuals with cancer in the year after diagnosis. Journal of Oncology Practice, 15(1), E20–E29. doi: 10.1200/JOP.18.00254.
3. Zheng, Y., Chen, Y., Yu, K., Yang, Y., Wang, X., Yang, X., Qian, J., Liu, Z.-X., & Wu, B. (2021). Fatal infections among cancer patients: A population-based study in the United States. Infectious Diseases and Therapy, 10(2), 871–895. https://doi.org/10.1007/s40121-021-00433-7 PMC